Supplier profile
Novartis Farmaceutica
Every public-sector award we hold for this supplier, across Spain and Mexico, from 23 Jan 2013 to 10 Oct 2024.
Awards won
456
all time
Attributed value
€4.1m + MXN 11.0bn
3 shared, unvalued
Buyers
7
public bodies
Active
2013–2024
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal | 4 | €3.5m |
| Comunidad de Madrid; Consejería de Sanidad; Hospital General Universitario Gregorio Marañón | 1 | €147k |
| Consorci de Salut i d'Atenció Social de Catalunya | 1 | not attributable |
| Hospital Universitario Central de Asturias | 1 | not attributable |
| Inspección General de Sanidad de la Defensa | 1 | €212k |
| Servicio Extremeño de Salud; Gerencia del Área de Salud de Badajoz | 1 | €332k |
| Servicio Murciano de Salud | 1 | not attributable |
What they win
Awards
Showing 126–150 of 456 awards we hold
- Adquisicion de Medicinas y Productos Farmaceuticos ↗£11.5m
- Contrataciones Consolidadas de Medicamentos 2023 ↗£348k
- Adquisicion de Medicamento y Bienes Terapeuticos 2022 ↗£113k
- Adquisición Consolidada de Medicamentos (Patente-Fuente Única) ↗£42.0m
- Adquisición Consolidada de Medicamentos Oncológicos Para el Ejercicio 2020 ↗£12.2m
- Adjudicación Directa de Medicamento Patente y Fuente Única E198-2021 ↗£4.2m
- Adjudicación Directa Intern. Consolidada No. Aa-051Gyn007-E30-2019, Medicamentos ↗£37.3m
- Medicamentos y Bienes Terapéuticos Para el Primer Semestre del2022 de Fuente Única (Bct) ↗£55k
- Adjudicación Directa Aa-012M7B997-E151-2022 Cons. (Ce-051Gyn007-E71-2022) ↗£316.8m
- Aa-012M7B998-E91-2021 Adq. Consol. de Medicamentos y Bienes Terapeuticos Fase 2 ↗£58k
- Medicinas y Productos Farmaceuticos ↗£128k
- Deferasirox Comprimido Cada Comprimido Contiene: Deferasirox 250 Mg Envase Con 2 ↗£219k
- Adjudicación Directa N° Aa-012M7B997-E133-2022 Para la Adquisición de Medicamentos de Patente (114 Claves) y Fuente Única (100 Claves) Para Los Ejercicios 2023-2024 (Ce-012Nbv001-E379-2022 ) ↗£56.2m
- Medicinas y Productos Farmaceuticos ↗£16k
- Consolidada de Medicamentos Oncologicos ↗£48.1m
- Adquisicion de Medicamento y Bienes Terapeuticos 2022 ↗£34k
- Contrataciones Consolidadas de Medicamentos 2023 ↗£62k
- Contratación Consolidada Adquisición Medicamentos Bienes Terapéuticos E197-2022 ↗£2.5m
- Adjudicación Directa Aa-006000993-E31-2020 Cons. (Ce-051Gyn007-E35-2020) ↗£66k
- Licitación Pública Intern Abierta Ssa No. La-12-512-012000991-I-174-2023 (Ce-051Gyn007-E20-2023) ↗£539k
- Adjudicación Dir. Cons. No. Aa-012000991-E340-2019 (Ce-051Gyn007-E34-2019), Med. ↗£27.1m
- Medicinas y Productos Farmacéuticos ↗£2.3m
- Contratación Consolidada Para la Adquisición de Medicamentos de Patente (114 Claves) y Fuente Unica (100 Claves) Para Los Ejercicios 2023-2024 Aa-012M7B997-E133-2022 ↗£7.9m
- Adquisición Consolidada de Medicamentos Adjudicación Directa 2024 ↗£35k
- Auxiliares de Diagnóstico Materiales, Accesorios y Suministros de Laboratorio ↗£11.3m
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.